Week of August 2, 2022 | Vol. 11, Issue 31

‌

In This Issue Upcoming Events Industry M&A Activity Recent Transactions Trading Comps Market Reports M&A Pipeline Featured Headlines Tanner Updates  Quick Links Who We Are M&A Discussion Group Daybreak Consumer Care Carlin Consumer Health Contact Information Xan Smith Managing Director Business Development xsmith@bourne-partners.com Jeremy C. Johnson Managing Director Head of M&A and Capital Advisory jjohnson@bourne-partners.com

Industry Snapshot Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.

UPCOMING EVENTS Events Hosted or Attended by Bourne Partners

NACDS Total Store Expo 2022 August 27-29, 2022 - Boston, MA

Contract Pharma Contracting & Outsourcing Conference September 22-23, 2022 - New Brunswick, NJ

Bourne Partners Global Executive Healthcare Summit October 12, 2022 - Charlotte, NC

BIO Europe October 24-26, 2022 - Leipzig, Germany

CPHI Worldwide November 1-3, 2022 - Messe Frankfurt, Germany

INDUSTRY M&A ACTIVITY Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

RECENT TRANSACTIONS An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A TRANSACTIONS

Pharma & Biotech 8 transactions totaling $32 million Supplies, Equipment & Services 20 transactions totaling $17 million Healthcare IT & Managed Care 10 transactions totaling $99 million  Healthcare Facilities & Distributors 8 transactions totaling $127 million

PRIVATE PLACEMENTS

Pharma & Biotech 38 transactions totaling $677 million Supplies, Equipment & Services 30 transactions totaling $728 million Healthcare IT & Managed Care 17 transactions totaling $205 million Healthcare Facilities & Distributors 3 transactions totaling $188 million

PUBLIC OFFERINGS

Pharma & Biotech 13 transactions totaling $714million Supplies, Equipment & Services 3 transactions totaling $7 million Healthcare IT & Managed Care 2 transactions totaling $10 million Healthcare Facilities & Distributors 1 transaction

TRADING COMPS A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

MARKET REPORTS Insight Into Healthcare Related Industries

eClinical Solutions Market Insight Report April 2022

Biostorage Services Market Insight Report April 2022

YE Pharma Services Sector Snapshot January 2022

M&A PIPELINE Representative Current Retained Sell-Side And Partnering Opportunities

Project Aman M&A / Capital Advisory |OTC | Branded Consumer Health Project Panther Sell-side| CDMO | Consumer Health and Medical Device

Project Power Play Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products Project Trident Buy-side | Generic Pharma | Manufacturing liquid generics

FEATURED HEADLINES A Sampling of Industry Headlines

ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC Bourne Partners - August 1, 2022

What Amazon's $4B One Medical play reveals about its healthcare ambitions Fierce Healthcare - July 25, 2022

Updated: Pisgah Labs announces $55 million expansion Transylvania Times - July 25, 2022

Medable forges pact with device developer Withings Health Solutions Fierce Biotech - July 26, 2022

Velocity Clinical Research buys site in Germany, marking EU expansion Fierce Biotech - July 27, 2022

PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments Business Wire - July 27, 2022

Amytrx Therapeutics Partners with CDMO AmbioPharm Contract Pharma - July 27, 2022

Labcorp to splice off clinical development arm into standalone business Fierce Biotech - July 28, 2022

TANNER NEWS

‌

LATAM MedTech Leaders Podcast Tanner Pharma President Steve Scalia sits down with Julio G. Martinez-Clark, CEO of Bioaccess, to discuss current healthcare trends and opportunities in LATAM and Tanner's role in enhancing patient access to medicines in this region. Listen here.

Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program Tanner and Ascentage Pharma have jointly launched an innovative Named Patient Program for olverembatinib to help expand access for patients with CML on a named patient basis in over 100 countries and regions where the drug is not yet commercially accessible. Read more.

Tanner Stories

There are two things Breanna Floyd brings to work in the morning and takes home in the evening – a smile and a sense of gratitude. She feels that Tanner’s support of customers and patients have made her take a step back and appreciate what she has. “We have access to medication and healthcare access at our fingertips, but so many don’t have that. That’s what we’re doing here. We are all trying to make a difference.” Read more here.

Jonathan Bracey started Tanner’s UK branch. During these early days he quickly found a place for himself building out the UK team and furthering the company’s global presence. All in all, JB regards the people at Tanner as family—a family of people helping people. The company cares about the employees who in turn show that same care to patients. And the cycle continues from there. Read more here.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.